brharris, can you post a link reg. this. I have been trying to find out the restricted period but couldn't find one. My assumption is that since AMBS is fully reporting company, the restricted period ends after six months under rule 144 registered securities.
Diogenix received 100 mil shares of restricted stock at the beginning of January so their restriction period should end in June. This is at price .08 per share but since PPS went down to .05 AMBS has to issue additional 60 mil shares to compensate for loss of equity.
Reginicin received 37.5 mil shares of restricted stock at .08 price per share. Since stock price went down AMBS has to issue additional 33 mil shares to compensate for loss of equity.
I'm pretty sure these shares not hit the market yet and will be converted before June unless they are restricted longer but I highly doubt it.
Series E 12% will be converted regardless. i.e about 500-700K.